PEARRL
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
Picture

Pharmaceutical Education And Research with Regulatory Links.

Model informed Drug Development
12th & 13th June 2019, National and Kapodistrian University of Athens, Athens

PEARRL is an EU research and training network focused on exploring new ways to streamline drug product development to facilitate earlier access to innovative new medicines.  Regulatory initiatives such as “Earlier Access to Medicines” (MHRA, 2014) and “Adaptive Licensing”(EMA, 2014) highlight the recent  increasing role regulatory agencies are playing in supporting this area[1].   A key objective of PEARRL is to increase awareness of advances in Regulatory Science (i.e. the science of “developing new tools, standards and approaches to assess the safety, efficacy, quality and performance of regulated products”). 

Building on the success of the 2017 and 2018 symposium, PEARRL will host a Symposium on Model Informed Drug Development at the National and Kapodistrian University of Athens, in Athens, on 12th & 13th 2019.

​The theme for Day 1 of the Open Symposium is "Lead optimisation through to pre-clinical development".  Day 2 of the symposium will be focused on "Clinical development through to pharmaceutical product lifecycle management".

An outline agenda for both days is provided below.

If you are interested in attending one or both days of the Symposia, you  should register your interest in attending on the field below. There is no charge for registration but places are limited, so you must register by the 31st May 2019 if you wish to attend. 
​

Download the programme and agenda

Day 1 - Agenda

Picture

Day 2 - Agenda (provisional)

Picture

Invited Speakers (Provisional list)

Picture
Dr. Bertil Abrahamsson
AstraZeneca R&D
Mölndal, Sweden
Picture
Apostolis Aivaliotis
Pharmathen S.A.
Marousi Attica, Greece
Picture
Dr. Jochem Alsenz
F. Hoffmann- La Roche Ltd.
Basel, Switzerland
Picture
Dr. James Butler
GlaxoSmithKline
Ware, UK
Picture
Sandy Van Hemelryck
Janssen Pharmaceutica
Belgium
Picture
Dr. Masoud Jamei
Certara
United Kingdom
Picture
Dr. Essam Ahmed Ghazaly Kerwash
The Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Picture
Ian Flawn Orpana
Verto Pharma AB, Sweden
Picture
Dr. Christian Wagner
Merck Group
Darmstadt, Germany
Picture
Neil John Parrott
F. Hoffmann- La Roche Ltd.
Basel, CH

About PEARRL
PEARRL is a European Training Network (ETN) funded under the Horizon 2020 Marie Sklodowska-Curie actions. It brings together European Pharma industry, academia and regulatory agency partners in a multisectorial team to deliver a unique research and training programme for 15 Early Stage Researchers (ESR).

The main research objectives of the PEARRL research programme are to deliver novel bio-enabling formulations and new biopharmaceutics tools to predict their in vivo performance as a means to improve efficiency and cost-competitiveness in drug development, thus facilitating earlier access of patients to “breakthrough therapies”.

PEARRL will train 15 Early Stage Researchers (ESR) who can develop such new bio-enabling formulations (“better drugs”), biorelevant and in silico methods to predict formulation performance in vivo (“streamlined development”) and serve as communication bridgers between research and regulatory science (“accelerated approval”), thus bringing Pharma and regulatory objectives to fruition.

Contacts

Picture
Prof. C. Reppas

Picture
Dr. Maria Vertzoni

Registration for the PEARRL  Symposium is now closed

For Non-PEARRLers to attend the 2-day open symposium they must be registered.

Certificate of attendance will not be provided to attendees.

Picture
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 674909.
Disclaimer | Member Area
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.